The Sociology of Medical Screening

Critical Perspectives, New Directions
Herausgegeben von Armstrong, Natalie; Eborall, Helen

• Broschiertes Buch

Produktbeschreibung

The Sociology of Medical Screening: Critical Perspectives, NewDirections presents a series of readings that provide anup-to-date overview of the diverse sociological issues relating topopulation-based medical screening.

Features new research data in most of the contributions
Includes contributions from eminent sociologists such as DavidArmstrong, Stefan Timmermans, and Alison Pilnick
Represents one of the only collections to specifically addressthe sociology of medical screening

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Sociology of Health and Illness Monographs .
• Verlag: Wiley & Sons
• 2. Aufl.
• Seitenzahl: 168
• Erscheinungstermin: 13. August 2012
• Englisch
• Abmessung: 229mm x 152mm x 5mm
• Gewicht: 254g
• ISBN-13: 9781118231784
• ISBN-10: 1118231783
• Artikelnr.: 35895399

Autorenporträt

Natalie Armstrong is lecturer in Social Science Applied to Health at the University of Leicester. A medical sociologist, Dr. Armstrong has previously held research posts at the University of Warwick and the London School of Hygiene and Tropical Medicine. Helen Eborall is lecturer in Social Science Applied to Health at the University of Leicester, having previously worked as a research fellow at the University of Cambridge.

Inhaltsangabe

Notes on Contributors vii
1 The sociology of medical screening: past, present and future 1
Natalie Armstrong and Helen Eborall
2 Screening: mapping medicine's temporal spaces 17
David Armstrong
3 The experience of risk as 'measured vulnerability': health screening and
lay uses of numerical risk 33
Chris Gillespie
4 Expanded newborn screening: articulating the ontology of diseases with
bridging work in the clinic 47
Stefan Timmermans and Mara Buchbinder
5 Resisting the screening imperative: patienthood, populations and politics
in prostate cancer detection technologies for the UK 60
Alex Faulkner
6 A molecular monopoly? HPV testing, the Pap smear and the molecularisation
of cervical cancer screening in the USA 73
Stuart Hogarth, Michael M. Hopkins and Victor Rodriguez
7 Blind spots and adverse conditions of care: screening migrants for
tuberculosis in France and Germany 90
Janina Kehr
8 'Let's have it tested first': choice and circumstances in decision-making
following positive antenatal screening in Hong Kong 105
Alison Pilnick and Olga Zayts
9 Representing and intervening: 'doing' good care in fi rst trimester
prenatal knowledge production and decision-making 121
Nete Schwennesen and Lene Koch
10 'Wakey wakey baby': narrating four-dimensional (4D) bonding scans 136
Julie Roberts
Index 151